Table 2 Unadjusted Outcomes in Overall Cohort and Subgroups
|  | Overall (n = 493) | Hispanic/Latino (n = 167) | Not Hispanic or Not Latino (n = 326) | ||||||
|---|---|---|---|---|---|---|---|---|---|
Parameter | Number of events (%) | Annual Incidencea | 5-year Incidence | Number of Events (%) | Annual Incidence | 5-year Incidence | Number of Events (%) | Annual Incidence | 5-year Incidence |
Ascites | 69 (14.0%) | 3.3% | 16% [13–21] | 31 (18.6%) | 5.2% | 25% [18–35] | 38 (11.7%) | 3.0% | 12% [8–17] |
Esophageal varices hemorrhage | 22 (4.5%) | 1.0% | 4% [3–8] | 7 (4.2%) | 1.1% | 5% [2–15] | 15 (4.6%) | 1.1% | 4% [2–8] |
Spontaneous bacterial peritonitis | 4 (0.8%) | 0.20% | 1% [0 - 3] | 2 (1.2%) | 0.3% | 1% [0 - 5] | 2 (0.6%) | 0.15% | 1% [0–4] |
Hepatic Encephalopathy | 52 (10.6%) | 2.5% | 13% [10–18] | 23 (13.8%) | 3.9% | 19% [13–28] | 29 (8.9%) | 2.3% | 10% [7–15] |
Hepatocellular Carcinoma | 24 (4.9%) | 1.1% | 7% [5–11] | 7 (4.2%) | 1.1% | 6% [3–14] | 17 (5.2%) | 1.3% | 8% [5–13] |
Liver transplant | 17 (3.5%) | 0.80% | 6% [3–9] | 9 (5.4%) | 1.4% | 10% [5–20] | 8 (2.5%) | 0.59% | 4% [2–8] |
MELD-3 score ≥ 15 | 48 (9.7%) | 2.3% | 12% [9–16] | 27 (16.2%) | 4.6% | 19% [14–28] | 21 (6.4%) | 1.6% | 8% [5–12] |
eCPT Score ≥ 7 | 81 (16.4%) | 4.1% | 19% [15–24] | 37 (22.2%) | 6.5% | 27% [20–36] | 44 (13.5%) | 3.6% | 15% [11–20] |
Decompensation symptomsb | 98 (19.9%) | 5.0% | 24% [20–29] | 38 (22.8%) | 6.8% | 31% [23–41] | 60 (18.4%) | 5.0% | 20% [16–26] |
Composite outcomec | 160 (32.5%) | 9.6% | 38% [33–43] | 62 (37.1%) | 11.7% | 46% [37–55] | 98 (30.1%) | 8.8% | 34% [28–40] |
All-cause Mortality | 70 (14.2%) | 3.4% | 16% [12–20] | 31 (18.6%) | 4.6% | 22% [16–31] | 39 (12.0%) | 2.8% | 12% [9–17] |
